The strong relation between post-hemodialysis blood methylglyoxal levels and post-hemodialysis blood glucose concentration rise

Clinical and Experimental Nephrology

Volumn 19, Issue 3, 2015, Pages 527-533

  Senda, Miho ^a   Ogawa, Susumu ^a,b   Nako, Kazuhiro ^a   Okamura, Masashi ^a   Sakamoto, Takuya ^a   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Continuous glucose monitoring system; Methylglyoxal; Post hemodialysis blood glucose fluctuations

Indexed keywords

DIALYSIS FLUID; GLUCOSE; INSULIN; METHYLGLYOXAL; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; ARTERIAL LINE; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HUMAN; INSULIN BLOOD LEVEL; INTRAVENOUS CATHETER; MALE; POSTOPERATIVE CARE; AGED; AMBULATORY MONITORING; BLOOD; DIABETES MELLITUS; MEAL; METABOLISM; MIDDLE AGED; PHYSIOLOGY; POSTPRANDIAL STATE; RENAL INSUFFICIENCY, CHRONIC;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LUNCH; MALE; MIDDLE AGED; MONITORING, AMBULATORY; POSTPRANDIAL PERIOD; PYRUVALDEHYDE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84931009286     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-014-1018-6     Document Type: Article

References (15)

1. Abe M, Kaizu K, Matsumoto K. Evaluation of the hemodialysis-induced changes in plasma glucose and insulin concentrations in diabetic patients: comparison between the hemodialysis and non-hemodialysis days. Ther Apher Dial. 2007;11:288–95.
2. Abe M, Kaizu K, Matsumoto K. Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose. Ther Apher Dial. 2007;11:280–7.
3. Abe M, Okada K, Matsumoto K. Plasma insulin and C-peptide concentrations in diabetic patients undergoing hemodialysis: comparison with five types of high-flux dialyzer membranes. Diabetes Res Clin Pract. 2008;82:e17–9.
4. Abe M, Okada K, Ikeda K, Matsumoto S, Soma M, Matsumoto K. Characterization of insulin adsorption behavior of dialyzer membranes used in hemodialysis. Artif Organs. 2011;35:398–403.
5. Odani H, Shinzato T, Matsumoto Y, Usami J, Maeda K. Increase in three alpha, beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction. Biochem Biophys Res Commun. 1999;256:89–93.
6. O’Byrne D, Devaraj S, Islam KN, Collazo R, McDonald L, Grundy S, Jialal I. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy. Metabolism. 2001;50:207–15.
7. Guo Q, Mori T, Jiang Y, Hu C, Osaki Y, Yoneki Y, Sun Y, Hosoya T, Kawamata A, Ogawa S, Nakayama M, Miyata T, Ito S. Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague–Dawley rats. J Hypertens. 2009;27:1664–71.
8. Randell EW, Vasdev S, Gill V. Measurement of methylglyoxal in rat tissues by electrospray ionization mass spectrometry and liquid chromatography. J Pharmacol Toxicol Methods. 2005;51:153–7.
9. Ogawa S, Nakayama K, Nakayama M, Mori T, Matsushima M, Okamura M, Senda M, Nako K, Miyata T, Ito S. Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressure. Hypertension. 2010;56:471–6.
10. Beisswenger PJ, Howell SK, O’Dell RM, Wood ME, Touchette AD, Szwergold BS. alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabetes Care. 2001;24:726–32.
11. Jia X, Olson DJ, Ross AR, Wu L. Structural and functional changes in human insulin induced by methylglyoxal. FASEB J. 2006;20:1555–7.
12. Schalkwijk CG, Brouwers O, Stehouwer CD. Modulation of insulin action by advanced glycation endproducts: a new player in the field. Horm Metab Res. 2008;40:614–9.
13. Dhar A, Desai KM, Wu L. Alagebrium attenuates acute methylglyoxal-induced glucose intolerance in Sprague-Dawley rats. Br J Pharmacol. 2010;159:166–75.
14. Jia X, Wu L. Accumulation of endogenous methylglyoxal impaired insulin signaling in adipose tissue of fructose-fed rats. Mol Cell Biochem. 2007;306:133–9.
15. Dhar A, Dhar I, Jiang B, Desai KM, Wu L. Chronic methylglyoxal infusion by minipump causes pancreatic beta-cell dysfunction and induces type 2 diabetes in Sprague-Dawley rats. Diabetes. 2011;60:899–908.